ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings
1. RMD reported Q2 earnings of $2.55, beating estimates. 2. Sales were $1.348 billion, surpassing analyst predictions. 3. Analysts raised price targets post-earnings, reflecting positive sentiment. 4. Shares rose 2.1% following the earnings announcement. 5. Demand for sleep and breathing health devices drove growth.